Stony Brook Team Given $4.2M Grant to Expand Promising Work in Advanced Prostate Cancer

Stony Brook Team Given $4.2M Grant to Expand Promising Work in Advanced Prostate Cancer
Researchers at Stony Brook University have been awarded a five-year, $4.2 million grant from the National Cancer Institute (NCI) to expand work into promising therapeutic agents against metastatic prostate cancer.  The team, led by Iwao Ojima, PhD, director of the Institute of Chemical Biology and Drug Discovery (ICB&DD) at Stony Brook, in collaboration with scientists at Cold Spring Harbor Laboratory and Artelo Biosciences, is examining a group of proteins called fatty acid-binding proteins (FABs) as targets to treat certain cancers, inflammatory conditions, and pain.  This new funding is based on work originally supported by a seed grant called a "Fusion Award" from the Renaissance School of Medicine at Stony Brook University. Ojima, along with Martin Kaczocha, PhD, an institute professor, and Cold Spring Harbor profess
Subscribe or to access all post and page content.